Related Experiment Video
Updated: Oct 14, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Mortality and bleeding complications of COVID-19 critically ill patients with venous thromboembolism
Daniel Gil-Sala1,2, Claudia Riera3, Marvin García-Reyes4,2
1Department of Angiology and Vascular Surgery, Hospital Universitari Vall d'Hebron - HUVH, Barcelona, Spain.
Insights
Critically ill COVID-19 patients in the ICU experience high rates of venous thromboembolism (VTE) but low bleeding risk. Admission D-dimer levels and other factors can predict mortality in these patients.
Area of Science:
- Critical care medicine
- Infectious diseases
- Hematology
Background:
- Venous thromboembolism (VTE) is a significant concern in COVID-19 patients, particularly regarding its association with bleeding and mortality.
- Understanding VTE outcomes in critically ill COVID-19 patients admitted to the Intensive Care Unit (ICU) is crucial.
Purpose of the Study:
- To describe the outcomes of critically ill COVID-19 patients in the ICU concerning VTE during their hospitalization.
- To identify predictors of VTE, bleeding events, and mortality in this patient population.
Main Methods:
- A prospective cohort study involving 230 critically ill COVID-19 patients across two hospitals.
- Venous ultrasound of both lower limbs was performed at baseline, with additional imaging for suspected new VTE during 30-day follow-up.
- Data collected included VTE frequency, major bleeding events, survival, and their associated predictors.
Main Results:
- A high frequency of VTE events (37.4%) was observed within 30 days.
- Major bleeding complications occurred in 5.7% of patients, and mortality was 18.3%.
- Admission D-dimer levels significantly correlated with VTE development and mortality. Independent predictors of mortality included older age, elevated D-dimer, and low lymphocyte count, achieving an AUC of 0.81.
Conclusions:
- Critically ill COVID-19 patients in the ICU exhibit a high incidence of VTE with a low risk of major bleeding.
- Admission laboratory parameters, such as D-dimer and lymphocyte count, alongside age, are valuable for predicting mortality in these patients.
Background:
Venous thromboembolism (VTE) disease in COVID-19 patients is a remarkable issue, especially its relationship with bleeding events and mortality. The objective of this study was to describe the outcomes of critically ill patients with COVID-19, hospitalized in the Intensive Care Unit (ICU), in relationship with VTE during their stay.
Methods:
This is a prospective cohort study of critically ill COVID-19 patients in two hospitals that underwent a venous ultrasound at the beginning of follow-up of both lower limbs in April 2020. In case of clinical suspicion of new VTE during the 30-day follow-up, additional ultrasound or thoracic CT were performed. Global VTE frequency, major bleeding events and survival were collected, and their predictors were studied.
Results:
We included 230 patients. After 30 days of follow-up, there were 95 VTE events in 86 patients (37.4%). Thirteen patients (5.7%) developed major bleeding complications and 42 patients (18.3%) died. None of the comorbidities or previous treatments were related with bleeding events. D-Dimer at admission was significantly related with VTE development and mortality. Independent predictors of mortality in the regression model were older age (>66 years), D-Dimer at admission (>1.500 ng/mL) and low lymphocyte count (<0.45×109/L) with an AUC in the ROC curve of 0.81 (95% CI: 0.73-0.89). Patients presenting these three conditions presented a mortality of 100% in the predictive model.
Conclusions:
VTE frequency in ICU COVID-19 patients is high and risk of major bleeding is low. Comorbidities and laboratory parameters of admission in these patients can be a useful tool to predict mortality.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pulmonary Embolism III: Nursing Management

